Skip to main content

Table 3 Between group differences in non-secluded patients

From: Prescribing preferences in rapid tranquillisation: a survey in Belgian psychiatrists and emergency physicians

  Nr 1 favoured product Top 3 favoured products
Psychiatrist (n = 71) Emergency physician (n = 37) Fisher’s exact p Psychiatrist (n = 71) Emergency physician (n = 37) Fisher’s exact p
Alprazolam LA 0 (0) 0 (0) 1 (1.4) 0 (0)
Alprazolam 1 (1.4) 1 (2.7) 1.000 4 (5.6) 3 (8.1) 0.689
Aripiprazole 3 (4.2) 0 (0) 0.55 7 (9.9) 0 (0) 0.093
Bromazepam 0 (0) 0 (0) 1 (1.4) 0 (0)
Clonazepam 0 (0) 0 (0) 0 (0) 1 (2.7)
Clorazepaat 2 (2.8) 2 (5.4) 0.605 9 (12.7) 7 (18.9) 0.404
Clotiapine 17 (23.9) 4 (10.8) 0.128 28 (39.4) 15 (40.5) 1.000
Diazepam 0 (0) 5 (13.5) 0.004 3 (4.2) 17 (45.9) <0.001
Droperidol 5 (7.0) 2 (5.4) 1.000 17 (23.9) 11 (29.7) 0.644
Escitalopram 0 (0) 0 (0) 0 (0) 2 (5.4) 0.115
Haloperidol 3 (4.2) 4 (10.8) 0.228 6 (8.5) 14 (37.8) <0.001
Lorazepam 14 (19.7) 9 (24.3) 0.625 43 (60.6) 15 (40.5) 0.067
Midazolam 0 (0) 2 (5.4) 0.115 0 (0) 6 (16.2) 0.001
Olanzapine 17 (23.9) 7 (18.9) 0.631 40 (56.3) 15 (40.5) 0.156
Paliperidone 0 (0) 0 (0) 1 (1.4) 0 (0)
Pipamperone 0 (0) 0 (0) 3 (4.2) 1 (2.7) 1.000
Prazepam 0 (0) 0 (0) 1 (1.4) 0 (0)
Promethiazine 0 (0) 0 (0) 0 (0) 1 (2.7)
Quetiapine 5 (7.0) 0 (0) 0.163 22 (31) 0 (0) <0.001
Risperidone 2 (2.8) 0 (0) 0.545 6 (8.5) 1 (2.7) 0.418
Trazodone 0 (0) 0 (0) 1 (1.4) 0 (0)
Sodium Valproate 0 (0) 1 (2.7) 4 (5.6) 1 (2.7) 0.659
Zuclopenthixol 0 (0) 0 (0) 2 (2.8) 1 (2.7) 1.000
Zuclopenthixol LA 2 (2.8) 0 (0) 0.545 14 (19.7) 0 (0) 0.002
  1. Fisher’s exact test was performed when one of the two groups had at least two counts (two-sided).
\